Press Release July 20, 2022

Triastek Announces Research Collaboration with Lilly

The Life Sciences team advised Triastek, Inc. on its collaboration with Eli Lilly and Company to leverage the advantages of 3D printing technology to enable precisely targeted and programmed release of drugs in specific regions of the GI tract.

Triastek is a global leader in the 3D printing of pharmaceuticals and is pioneering the implementation of digital pharmaceutical solutions. 

The Goodwin team was led by Can Cui.

For more details, read the press release and article in Fierce Pharma.